Recursion Pharmaceuticals Inc RXRX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD

After Hours: Last | 05/17/24 EDT

9.33

-0.09 (-0.96%)

Volume

179,027

9.42

-0.09 (-0.95%)

Volume

4,522,710

52 week range

4.97 - 16.75

Open9.50
Day High9.58
Day Low9.17
Prev Close9.51
52 Week High16.75
52 Week High Date07/19/23
52 Week Low4.97
52 Week Low Date11/01/23

Key Stats

Market Cap2.239B
Shares Out237.66M
10 Day Average Volume6.08M
Dividend-
Dividend Yield-
Beta0.85
YTD % Change-4.46

KEY STATS

Open9.50
Day High9.58
Day Low9.17
Prev Close9.51
52 Week High16.75
52 Week High Date07/19/23
52 Week Low4.97
52 Week Low Date11/01/23
Market Cap2.239B
Shares Out237.66M
10 Day Average Volume6.08M
Dividend-
Dividend Yield-
Beta0.85
YTD % Change-4.46

RATIOS/PROFITABILITY

EPS (TTM)-1.60
P/E (TTM)-5.88
Fwd P/E (NTM)-5.46
EBITDA (TTM)-347.135M
ROE (TTM)-85.19%
Revenue (TTM)46.235M
Gross Margin (TTM)10.66%
Net Margin (TTM)-765.90%
Debt To Equity (MRQ)0.28%

EVENTS

Earnings Date08/06/2024(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Recursion Pharmaceuticals Inc

The restaurant stocks that are killing it right now have this one thing in commonMay 12, 2024CNBC.com
We've built an unbiased platform that lets data drive decisions, not us, says Recursion CEOMay 10, 2024CNBC.com
Recursion Pharmaceuticals CEO Chris Gibson goes one-on-one with Jim CramerMay 10, 2024CNBC.com
Recursion Pharmaceuticals CEO says AI will make drug development faster, cheaperMay 10, 2024CNBC.com
Lightning Round: Casey's General Store is a 'hidden gem', says Jim CramerApril 23, 2024CNBC.com

Content From Our Affiliates

Recursion Pharmaceuticals call volume above normal and directionally bullishMay 14, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Carisma Therapeutics (CARM) and Recursion Pharmaceuticals (RXRX)May 14, 2024TipRanks
Recursion Pharmaceuticals: A Buy Rating with Growth and Innovation on the HorizonMay 10, 2024TipRanks
Recursion Pharmaceuticals reports Q1 EPS (39c), consensus (42c)May 9, 2024TipRanks
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9May 2, 2024TipRanks

Profile

Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into...

R. Martin Chavez Ph.D.

Independent Chairman of the Board

Christopher Gibson Ph.D.

Chief Executive Officer, Director

Tina Larson

President, Chief Operating Officer

Michael Secora Ph.D.

Chief Financial Officer

Address

41S Rio Grande Street

Salt Lake City, UT

84101

United States

https://www.recursion.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
ARVN Arvinas Inc	32.68	+0.57	+1.78%
RCKT Rocket Pharmaceuticals Inc	22.62	-0.78	-3.33%
AGIO Agios Pharmaceuticals Inc	34.34	-0.66	-1.89%
KROS Keros Therapeutics Inc	52.28	-1.71	-3.17%
NTLA Intellia Therapeutics Inc	26.22	+0.05	+0.19%